Skip to content

The Effect of Acupuncture Protocol Involving in Weizhong (BL4) and Huantiao (GB30) Points in Treating Ankylosing Spondylitis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02260310
Enrollment
100
Registered
2014-10-09
Start date
2014-10-31
Completion date
2018-01-31
Last updated
2017-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankylosing Spondylitis

Brief summary

The purpose of this study is to evaluate the effect of acupuncture protocol involving in Weizhong (BL4) and Huantiao (GB30) points in treating ankylosing spondylitis.

Interventions

OTHERWeizhong and Huantiao
OTHERA-shi point

Sponsors

Chengdu PLA General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Eligible adult (≥18 years of age) patients * had a diagnosis of AS for at least 3 months defined as definite by the 1984 modified New York criteria * Eligible patients also had a Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) of ≥4 (0-10 cm scale) * A visual analogue scale (VAS) score for total back pain of ≥4 (0-10 cm scale)

Exclusion criteria

* Had received prior Acupuncture therapy * With complete ankylosis of the spine, defined as the presence of bridging syndesmophytes at all intervertebral levels of the cervical and lumbar spine on lateral view spinal radiographs

Design outcomes

Primary

MeasureTime frame
Change from Baseline in McGill Pain Questionnaire (MPQ) at 12 weeksAt 0 week, 6 weeks, 12 weeks
Change from Baseline in Visual Analog Scale at 12 weeksAt 0 week, 6 weeks, 12 weeks

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026